Literature DB >> 19820721

Inhibitory effects of tanshinone II-A on invasion and metastasis of human colon carcinoma cells.

Yun-feng Shan1, Xian Shen, Yuan-kang Xie, Ji-cai Chen, Hong-qi Shi, Zheng-ping Yu, Qi-tong Song, Men-tao Zhou, Qi-yu Zhang.   

Abstract

AIM: To investigate the effects and possible mechanisms of tanshinone II-A, an alcohol extract of the root of Salvia miltiorrhiza Bunge, on tumor invasion and metastasis of human colon carcinoma (CRC) cells.
METHODS: The effects of tanshinone II-A on invasion and metastasis of CRC cell lines HT29 and SW480 were evaluated by in vitro and in vivo assays. Western blotting was used to investigate possible molecular mechanisms of tanshinone II-A anti-cancer actions.
RESULTS: Tanshinone II-A inhibited migration and invasion of CRC cells in a dose-dependent manner. The inhibitory effect also depended on time, with the most significant effects observed at 72 h. Tanshinone II-A also significantly inhibited in vivo metastasis of colon carcinoma SW480 cells. It inhibited in vitro and in vivo invasion and metastasis of CRC cells by reducing levels of urokinase plasminogen activator (uPA) and matrix metalloproteinases (MMP)-2 and MMP-9, and by increasing levels of tissue inhibitor of matrix metalloproteinase protein (TIMP)-1 and TIMP-2. Tanshinone II-A was also shown to suppress the nuclear factor-kappaB (NF-kappaB) signal.
CONCLUSION: Tanshinone II-A inhibited in vitro and in vivo invasion and metastasis of CRC cells. The effect resulted from changes in the levels of uPA, MMP-2, MMP-9, TIMP-1 and TIMP-2, and apparent inhibition of the NF-kappaB signal transduction pathway.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19820721      PMCID: PMC4003002          DOI: 10.1038/aps.2009.139

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  42 in total

1.  Inhibition with antisense oligonucleotide suggests that IkappaB-alpha does not form a negative autoregulatory loop for NF-kappaB in mesangial cells.

Authors:  R B Auwardt; S J Mudge; C Chen; D A Power
Journal:  Exp Nephrol       Date:  2000 May-Jun

2.  [Experimental study on anti-angiogenesis in mice with Lewis lung carcinoma by low-dose of cyclophosphamide combined with ginsenoside Rg3].

Authors:  Xin-Mei Kang; Qing-Yuan Zhang; Dan-Dan Tong; Wenhui Zhao
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  2005-08

3.  E-cadherin germline mutations in familial gastric cancer.

Authors:  P Guilford; J Hopkins; J Harraway; M McLeod; N McLeod; P Harawira; H Taite; R Scoular; A Miller; A E Reeve
Journal:  Nature       Date:  1998-03-26       Impact factor: 49.962

4.  Inhibition of cell-cycle effectors of proliferation in bladder tumor epithelial cells by the p75NTR tumor suppressor.

Authors:  Fatima Khwaja; Daniel Djakiew
Journal:  Mol Carcinog       Date:  2003-03       Impact factor: 4.784

5.  Matrix metalloproteinases and their inhibitors in gastric cancer.

Authors:  G I Murray; M E Duncan; E Arbuckle; W T Melvin; J E Fothergill
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

6.  Cytotoxic activities of tanshinones against human carcinoma cell lines.

Authors:  W L Wu; W L Chang; C F Chen
Journal:  Am J Chin Med       Date:  1991       Impact factor: 4.667

7.  Tanshinone IIA from Salvia miltiorrhiza BUNGE inhibits human aortic smooth muscle cell migration and MMP-9 activity through AKT signaling pathway.

Authors:  Un-Ho Jin; Seok-Jong Suh; Hyen Wook Chang; Jong-Keun Son; Seung Ho Lee; Kun-Ho Son; Young-Chae Chang; Cheorl-Ho Kim
Journal:  J Cell Biochem       Date:  2008-05-01       Impact factor: 4.429

Review 8.  Colon cancer overview.

Authors:  P Greenwald
Journal:  Cancer       Date:  1992-09-01       Impact factor: 6.860

Review 9.  Epidemiology of cancer in the United States.

Authors:  J L Cresanta
Journal:  Prim Care       Date:  1992-09       Impact factor: 2.907

10.  p75 neurotrophin receptor suppresses the proliferation of human gastric cancer cells.

Authors:  Haifeng Jin; Yanglin Pan; Lina Zhao; Huihong Zhai; Xiaohua Li; Li Sun; Lijie He; Yu Chen; Liu Hong; Yulei Du; Daiming Fan
Journal:  Neoplasia       Date:  2007-06       Impact factor: 5.715

View more
  16 in total

Review 1.  Development and progression of colorectal neoplasia.

Authors:  Upender Manne; Chandrakumar Shanmugam; Venkat R Katkoori; Harvey L Bumpers; William E Grizzle
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

2.  Tanshinone IIA enhances chemosensitivity of colon cancer cells by suppressing nuclear factor-κB.

Authors:  Yangqiu Bai; Lida Zhang; Xinhui Fang; Yuxiu Yang
Journal:  Exp Ther Med       Date:  2016-01-12       Impact factor: 2.447

3.  Integrating transcriptomics and proteomics to show that tanshinone IIA suppresses cell growth by blocking glucose metabolism in gastric cancer cells.

Authors:  Li-Ling Lin; Chieh-Ren Hsia; Chia-Lang Hsu; Hsuan-Cheng Huang; Hsueh-Fen Juan
Journal:  BMC Genomics       Date:  2015-02-05       Impact factor: 3.969

4.  Tanshinone IIA attenuates bleomycin-induced pulmonary fibrosis in rats.

Authors:  Huanyu He; Haiying Tang; Lili Gao; Yun Wu; Zhiqiang Feng; Hongli Lin; Taihua Wu
Journal:  Mol Med Rep       Date:  2015-02-11       Impact factor: 2.952

5.  Tan IIA inhibits H1299 cell viability through the MDM4‑IAP3 signaling pathway.

Authors:  Yukun Zu; Jianning Wang; Wei Ping; Wei Sun
Journal:  Mol Med Rep       Date:  2017-11-24       Impact factor: 2.952

6.  Salvia miltiorrhiza extract inhibits TPA-induced MMP-9 expression and invasion through the MAPK/AP-1 signaling pathway in human breast cancer MCF-7 cells.

Authors:  Jeong-Mi Kim; Eun-Mi Noh; Hyun-Kyung Song; Minok Lee; Soo Ho Lee; Sueng Hyuk Park; Chan-Keun Ahn; Guem-San Lee; Eui-Baek Byun; Beom-Su Jang; Kang-Beom Kwon; Young-Rae Lee
Journal:  Oncol Lett       Date:  2017-07-20       Impact factor: 2.967

Review 7.  Tanshinones: sources, pharmacokinetics and anti-cancer activities.

Authors:  Yong Zhang; Peixin Jiang; Min Ye; Sung-Hoon Kim; Cheng Jiang; Junxuan Lü
Journal:  Int J Mol Sci       Date:  2012-10-22       Impact factor: 5.923

8.  Potential therapeutic roles of tanshinone IIA in human bladder cancer cells.

Authors:  Sheng-Chun Chiu; Sung-Ying Huang; Shu-Fang Chang; Shee-Ping Chen; Chi-Cheng Chen; Tien-Huang Lin; Hsin-Ho Liu; Tsung-Hsun Tsai; Shang-Sen Lee; Cheng-Yoong Pang; Teng-Fu Hsieh
Journal:  Int J Mol Sci       Date:  2014-09-04       Impact factor: 5.923

9.  Tanshinones and diethyl blechnics with anti-inflammatory and anti-cancer activities from Salvia miltiorrhiza Bunge (Danshen).

Authors:  Hongwei Gao; Wen Sun; Jianping Zhao; Xiaxia Wu; Jin-Jian Lu; Xiuping Chen; Qiong-Ming Xu; Ikhlas A Khan; Shilin Yang
Journal:  Sci Rep       Date:  2016-09-26       Impact factor: 4.379

Review 10.  Recent insights into the biological activities and drug delivery systems of tanshinones.

Authors:  Yuee Cai; Wenji Zhang; Zirong Chen; Zhi Shi; Chengwei He; Meiwan Chen
Journal:  Int J Nanomedicine       Date:  2016-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.